Healthcare

IRONWOOD PHARMACEUTICALS INC

Ticker: IRWD

Exchange: US

Composite FIGI: BBG000GBZ3J2

Total Alternative Signals

1signals tracked

Weighted Sentiment

+0.85weighted index

Avg Materiality Score

4.0/ 5.0 scale

Signal Distribution

1▲|0■|0▼

Alternative Data Signal Feed

Real-Time Ingestion Active

Unlock Alternative Signals Feed

Access the complete, parsed materiality analysis, long-term investment theses, and direct feed links for IRONWOOD PHARMACEUTICALS INC. Programmatic API and Webhooks available.

Get Premium API Key How does alternative data signal modeling work?

Earnings ReportBullish

Filing Date: 2026-06-12

Signal Event Report - FIGI BBG000GBZ3J2

Ironwood Pharmaceuticals expects strong momentum for Linzess, projecting increased revenues and profit through 2026 due to robust demand, pediatric expansion, and pricing changes.

Quantitative Investment Thesis

The anticipated continued growth of Linzess, a key product, driven by market expansion and strategic pricing, reinforces Ironwood's long-term revenue stability and profitability. This outlook strengthens the investment case for sustained financial performance.

Materiality & Sentiment Scores

Sentiment: 0.85

Materiality: 4 / 5

Source Document: https://finance.yahoo.com/sectors/healthcare/articles/linzess-continue-driving-irwds-revenue-133800682.html?.tsrc=rss